Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (Diluted Average) (2021 - 2023)

Historic Shares Outstanding (Diluted Average) for Cullinan Therapeutics (CGEM) over the last 3 years, with Q3 2023 value amounting to $42.7 million.

  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) fell 825.68% to $42.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.7 million, marking a year-over-year decrease of 825.68%. This contributed to the annual value of $46.6 million for FY2022, which is 827.12% up from last year.
  • As of Q3 2023, Cullinan Therapeutics' Shares Outstanding (Diluted Average) stood at $42.7 million, which was down 825.68% from $40.3 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Shares Outstanding (Diluted Average) high stood at $46.6 million for Q4 2022, and its period low was $40.3 million during Q2 2023.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $43.4 million (2021), whereas its average is $43.8 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Shares Outstanding (Diluted Average) skyrocketed by 827.12% in 2022 and then plummeted by 1309.36% in 2023.
  • Cullinan Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $43.1 million in 2021, then grew by 8.27% to $46.6 million in 2022, then decreased by 8.37% to $42.7 million in 2023.
  • Its last three reported values are $42.7 million in Q3 2023, $40.3 million for Q2 2023, and $40.7 million during Q1 2023.